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Type 2 diabetes mellitus (T2DM) occurs in 95% of the diabetic populations. Management of T2DM is a challenge. Traditional
Chinese medicines (TCM) are usually served as adjuvants used to improve diabetic syndromes in combination of routine
antidiabetic drugs. For single-herb prescriptions, Ginseng, Bitter melon, Golden Thread, Fenugreek, Garlic, and Cinnamon might
have antidiabetic eﬀects in T2DM patients. Among 30 antidiabetic formulas approved by the State Food and Drugs Administrator
of China, top 10 of the most frequently prescribed herbs are Membranous Milkvetch Root, Rehmannia Root, Mongolian
SnakegourdRoot,Ginseng,ChineseMagnoliavineFruit,KudzuvineRoot,DwarfLilyturfTuber,CommonAnemarrhenaRhizome,
Barbary Wolfberry Fruit, and India Bread, which mainly guided by the theory of TCM. Their action mechanisms are related to
improveinsulinsensitivity,stimulateinsulinsecretion,protectpancreaticislets,andeveninhibitintakeofintestinalcarbohydrates.
However, it is very diﬃcult to determine antihyperglycemic components of TCM. Nevertheless, TCM are becoming popular
complementary and alternative medicine in treatment of syndromes of T2DM. In the future, it requires further validation of
phytochemical, pharmacological, and clinical natures of TCM in T2DM in the future studies, especially for those herbs with a high
prescription frequency.
1.Introduction
Diabetes mellitus is associated with the increase in cardio-
vascular diseases and other complications [1–4]. There is
increasing incidence of the disease. Type 2 diabetes mellitus
(T2DM) occurs in 95% of the diabetic populations. Man-
agement of T2DM is a challenge. Plants play an important
role in introducing new medicines with antidiabetic activ-
ities, such as antidiabetic drugs, biguanidines derives from
guanidine of French lilac (Galega oﬃcinalis). Traditional
and modern Chinese medicines are becoming the important
sources for the development of antidiabetic drugs [5–10].
There is an increasing need for those T2DM patients intol-
erant of adverse eﬀects of chemical drugs and/or those who
cannot aﬀord expensive medical expenditures in developing
countries.
There are some original or review papers on herbal
medicines in treatment of T2DM [5–7]. They supply some
useful information of sources, active principles, phytochem-
istry, and pharmacology of traditional Chinese medicines
(TCM) with antidiabetic activities. However, there is still
insuﬃcient evidence to draw deﬁnitive conclusions about
the eﬃcacy of TCM for diabetes. Li et al. systemically list
many TCM with antidiabetic eﬀects but have not showed
those antidiabetic formula products which are mainstay of
TCM [6]. Liu et al. indicate some TCM including single herb
prescriptions and formula in treatment of T2DM but most
of these herb medicines do not belong to regular products of
TCMapprovedtobeusedclinically[7].ThoughJiaetal.have
reviewed the antidiabetic herbal drugs oﬃcially approved in
China [5] but show only eight antidiabetic herbal formulas,
it is not enough to display special aspects of TCM.
In this paper, we updated and supplemented some
reputed TCM approved by the State Food and Drugs
Administrator (SFDA) in China mainland in the treatment
of T2DM and tried to supply some worthy herb sources and2 Evidence-Based Complementary and Alternative Medicine
conduct a discussion on how to develop TCM in treatment
of T2DM.
2. Methods
We searched for papers published in MEDLINE, CNKI,
EMBASE, Wiley InterScience, Elselvier databases with-
out language limit by retrieving key words “herb/plant,
clinic/clinical, human/patients, type 2 diabetes mellitus” to
identify herb medicines in treatment of type 2 diabetes;
only those paper with clinical trials will be selected. For
Chinese herb formulas, only those listed in the database
of products with antidiabetic eﬀect in the oﬃcial website
of http://www.sfda.gov.cn/ will be retrieved. These searches
were conducted by two independent examiners. The last date
of the search was December 1, 2010.
3. Results
3.1. Single-Herb Prescriptions. There were only a few reputed
single-herb prescriptions found in China. Although those
singleherbprescriptionshadreputedrecordsor/andpromis-
ing clinical results, they still served as adjuncts or supple-
ments for T2DM patients.
3.2. Ginseng. Ginseng together with its roots, stalk, leaves,
and berries had signiﬁcant antihyperglycemic eﬀect in many
animal models of T2DM. Some clinical studies indicated
that Ginseng is an emerging alternative therapy for T2DM
[11–13]. Ginseng signiﬁcantly decreased insulin resistance
and fasting blood glucose (FBG) in T2DM patients [14, 15].
In china, among 30 cases of T2DM treated with Renshen
tangtai, an injection contained Ginseng polypeptide and
polysaccharides; 86.7% of the patients showed apprecia-
ble eﬀect on diabetic symptoms [16]. However, Ginseng
had no eﬀect on indices of glucose regulation following
acute or chronic ingestion in healthy volunteers [17]. Its
active compounds with antihyperglycemic eﬀects included
ginsenosides, polypeptide [18], and polysaccharides [19].
Ginsengmightexertaantihyperglycemiceﬀectbypromoting
insulin secretion [11], protecting pancreatic islets [20], stim-
ulatingglucoseuptake[21],andenhancinginsulinsensitivity
[15]. Future studies require identifying the component(s)
of Ginseng [22]. Ginseng had no signiﬁcant side eﬀects
[15]. However, chronic overdosed administration of Ginseng
may suﬀer from gastrointestinal, mental, cardiovascular, and
hormone disorders. Children and pregnant women should
be cautious of using this herb.
3.3. Golden Thread. Golden Thread is commonly used to
treatdiabetesinChina.Berberineisanisoquinolinealkaloids
and the active ingredient of Golden Thread. Berberine had
a signiﬁcant antihyperglycemic eﬀe c ti nb o t h3 6p a t i e n t s
newlydiagnosedwithT2DMandalsoin48poorlycontrolled
patients with T2DM [23]. This eﬀect was comparable to
metformin. Berberine increased glucose uptake and stim-
ulates glycolysis by activation of AMP-activated protein
kinase (AMPK) [24, 25]. In addition, berberine promoted
insulin secretion by modulating glucagon-like peptide-1
release [26]. Berberine promoted beta cell regeneration [27].
In intestinal region, berberine inhibited glucose absorp-
tion by suppressing disaccharidase activities [28]. Expect
for transient gastrointestinal adverse eﬀects, no signiﬁcant
functional liver or kidney damages were documented.
3.4. Bitter Melon. Bitter melon is more commonly used by
persons from Asian countries. Bitter melon lowered fasting
and postprandial serum glucose levels in T2DM patients
[29]. Although bitter melon might have antihyperglycemic
eﬀects, data were not suﬃcient to recommend its use in
the absence of careful supervision and monitoring [30].
Major active compounds in this plant contained cucurbitane
triterpenoids[31],polypeptide-p,charantin,andvicine[32].
Bitter melon exerted a antihyperglycemic eﬀect by inhibition
of protein tyrosine phosphatase 1B (PTP1B), activation of
AMPK, increase of glucose transporter type 4 (GLUT4)
expression, promotion of the recovery of beta cells [33], and
insulin-mimicking action [34]. However, adverse eﬀects of
bitter melon included hypoglycemic coma and convulsions
in children and headaches [35]. Bitter melon might have
additive eﬀects when taken with other glucose-lowering
agents. Despite this, no serious adverse eﬀects were reported
in all the clinical trials. There were no documentations of
death from any cause, morbidity, (health-related) quality of
life, and costs [36].
3.5. Fenugreek. F e n u g r e e ki m p r o v e db l o o dg l u c o s ec o n t r o l
and insulin resistance in diabetic patients [37–39]. The
ﬁndings of 18 cases of patients showed that FBG, triglyc-
erides, and very low-density lipoprotein cholesterol (VLDL-
C) decreased signiﬁcantly after taking fenugreek seed soaked
in hot water [40]. Combined therapy of total saponins of
Fenugreek with sulfonylureas hypoglycemic drug lowered
the blood glucose level and ameliorated clinical symptoms
in 46 cases of T2DM compared with 23 cases of controls
[41]. Active components of Fenugreek included trigonelline,
nicotinic acid, GII [42], diosgenin [43], 4-hydroxyisoleucine
[44], total saponins [45], Fenugreek oil [46], and soluble
dietary ﬁbre fraction [47]. Its antihyperglycemic mecha-
nisms were associated with potentiating insulin secretion,
increasing insulin sensitivity [48], and inhibiting intestinal
carbohydrate digestion and absorption [47]. Fenugreek was
relatively safe [45] and also had no genotoxicity [49].
However, we should be cautious of its use combined with
aspirin in case of the risk of bleeding [50].
3.6. Garlic. Garlic had antihyperglycemic and antihyper-
lipidemic eﬀects in T2DM patients [51, 52]. In the 4-
week double-blinded placebo-controlled study in 60 T2DM
patients, Garlic lowered FBG, serum fructosamine, and
serum triglyceride levels [53]. Garlic constituents mainly
includedsulfur-containingcompounds(e.g.,diallyltrisulﬁde
[54], ajoene [55], S-allyl cysteine sulfoxide [56]) and garlic
oil. Garlic improved glycemic control through increased
insulin secretion and enhanced insulin sensitivity [54].
Garlic had no signiﬁcant adverse eﬀects. However, we shouldEvidence-Based Complementary and Alternative Medicine 3
be cautious of excess and chronic administration of garlic
because of gastrointestinal troubles. If patients suﬀered from
hepatitis, kidney and heart diseases, intake of garlic should
be prohibited [57].
3.7. Cinnamon. The oral administration of cinnamon per
day reduced serum glucose and lipid levels in patients with
T2DM, suggesting that the inclusion of cinnamon in the diet
of patients with T2DM would reduce risk factors associated
with diabetes and cardiovascular diseases [58]. Cinnamon
lowered hemoglobin A1c (HbA1C) by 0.83% compared with
usual care alone lowering HbA1C by 0.37% in patients with
T2DM in a randomized, controlled trial [59]. Its active com-
ponents contained cinnamaldehyde [60] and naphthalen-
emethyl ester derivative [61]. Its antihyperglycemic eﬀects
were worked by promoting insulin release, enhancing insulin
sensitivity, and increasing glucose disposal. Also, Cinnamon
seemed to exert insulin-like eﬀects through regulation of
PTP1B and insulin receptor kinase [62]. Cinnamon had no
signiﬁcant adverse eﬀects but may be of concern when used
in excessive amounts [63].
3.8. Traditional Chinese Formulas. In this paper, we listed
30 traditional Chinese herbal formulas approved by China
SFDA (Table 1). Although these formulas are listed in
China SFDA website, we had no authorized access to their
unpublished clinical data. Only part of them is published
in the open journals but mostly in Chinese journals. Most
of these Chinese formulas were used in combination with
routine compounds such as glibenclamide or metformin and
indicatethattheyhadbettereﬀectsinloweringbloodglucose
and improving diabetic symptoms than routine drugs alone
in T2DM patients. In two Chinese formulas, glibenclamide
was directly added and considered as a component of
formulas. A very small amount of Chinese formulas were
used as monotherapy in slight or mild cases of T2DM.
Among30formulasabove,welisted3ormorethan3fre-
quently prescribed herbs in Figure 1. Top 10 of the most fre-
quently prescribed herbs were Membranous Milkvetch Root,
Rehmannia Root, Mongolian Snakegourd Root, Ginseng,
ChineseMagnoliavineFruit,KudzuvineRoot,DwarfLilyturf
Tuber, Common Anemarrhena Rhizome, Barbary Wolfberry
Fruit, and India Bread. According to the theory of TCM,
these herbs could be grouped as Qi (energy-) invigorating,
Yin (body ﬂuids-) nourishing, heat (body heat-) clearing
andstasis-reducing(improvingbloodcirculationandkidney
function) drugs (Table 2). For Qi-invigorating drugs, the
mostfrequentlyprescribedherbwasMembranousMilkvetch
Root (Huang qi, 23 in 30). For Yin-nourishing drugs, the
most frequently prescribed herb was Mongolian Rehmannia
Root (Di huang, 22 in 30). For heat-clearing drugs, the
mostfrequentlyprescribedherbwasCommonAnemarrhena
Rhizome (Zhi mu, 12 in 30). For stasis-reducing drugs, the
most frequently prescribed herb was India Bread (Fu ling, 10
in 30).
3.9. Yuquan Wan. Yuquan Wan (YQW) has been long used
to treat diabetes in Chinese medicines. Among 18 diabetic
patients treated with Yuquan Wan for 1 month [64], 72%
casesshowedsigniﬁcantormoderateimprovementinfasting
blood glucose and other diabetic symptoms such as thirst
and hunger disappeared. In relation to diabetic complica-
tions, Yuquan Wan improved the index of kidney injures
of early diabetic nephropathy in diabetic patients, which
suggested that it would prolong the development of diabetic
nephropathy [65].YQWimproved theinsulin resistance[66]
in patients with T2DM. YQW reduced the levels of the
increasedproinﬂammatorycytokinesinpatientswithT2DM
[67]. YQW had a signiﬁcant eﬀect on the pharmacokinetics
of metformin hydrochloride in diabetic rats [68]. This might
explain why YQW had a better eﬀect than metformin alone.
Taken together, YQW mainly improved diabetic compli-
cations and exerted a antihyperglycemic eﬀect mediated
likely by enhancing insulin sensitivity. No signiﬁcant adverse
eﬀects were reported of YQW.
3.10. Tangmaikang Jiaonang. Tangmaikang Jiaonang (TMK)
is used to treat T2DM and its complications. There were
many clinical reports of TMK with good eﬀects in treatment
of T2DM [69, 70], insulin resistance [71, 72], dyslipidemia
[73], diabetic peripheral neuropathy, and blood ﬂuid param-
eters [69, 74]. These results were drawn only by comparing
between before and after combined treatment with routine
antidiabetic drugs such as sulfonylureas or biguanides. One
clinical report showed that TMK had a better eﬀect in
treatment of T2DM patients than Xiaoke Wan [75]. TMK
could treat T2DM and could reduce hypoglycemia and the
dose of insulin at the base of controlled blood glucose
[76]. TMK combined with metformin had better eﬀect
than metformin alone in newly diagnosed T2DM patients
[77]. TMK enhanced the eﬀect of routine drug on diabetic
peripheral neuropathy [78]. TMK combined with routine
drugs had more improvement in blood ﬂuid parameters
than routine drugs alone [79]. TMK mainly improved
diabetic complications and exerted an antihyperglycemic
eﬀect mediated by increasing insulin sensitivity but mostly
used in combination with the regular antihyperglycemic
measurements. There were no signiﬁcant adverse eﬀects
reported in the previous studies.
3.11. Xiaoke Wan. Xiaoke Wan (XKW) contains several
herb medicines and a western compound, glibenclamide.
It is used to treat T2DM. Many clinical reports showed
that XKW had similar or better antihyperglycemic eﬀects
in diabetic patients compared with glibenclamide [80–84].
In these reports, about 82% (n = 61) [80], 94.1% (n =
86) [81], 92% (n = 100) [82], 93.8 (n = 300) [83],
and 98% (n = 137) [84] of T2DM patients had sig-
niﬁcant or moderate improvement in hyperglycemia and
other diabetic symptoms, respectively. XKW had more
improvement in other diabetic symptoms such as thirsty
and hungry or complications such as blood lipid and blood
ﬂuid parameters than glibenclamide. Besides of stimulation
of insulin secretion mediated by glibenclamide (one of
components in XKW), XKW enhanced insulin sensitivity
likely mediated by promoting adiponectin secretion in4 Evidence-Based Complementary and Alternative Medicine
Table 1: Chinese herbal formulas approved by China SFDA.
No. Products Ingredients
1 Yuquan Wan
Kudzuvine Root (Ge gen), Mongolian Snakegourd Root (Tian hua fen), Rehmannia Root
(Di huang), Dwarf Lilyturf Tuber (Mai dong), Chinese Magnoliavine Fruit (Wu wei zi),
Liquoric Root (Gan cao)
2 Tangmaikang
Keli
Membranous Milkvetch Root (Huang qi), Rehmannia Root (Di huang), Danshen Root
(Dan shen), Medicinal Cyathula Root (Niu xi), Dwarf Lilyturf Tuber (Mai dong), King
Solomonseal Rhizome (Huang jing), etc.
3X i a o k e W a n
Membranous Milkvetch Root (Tian hua fen), Rehmannia Root (Di huang), Mongolian
Snakegourd Root (Ge gen), Kudzuvine Root (Huang qi), Wingde Yan Rhizome (Shan
yao), Corn Stigma (Yu mi xu), Chinese Magnoliavine Fruit (Wu wei zi), and glibenclamide
4 Jinqi Jiangtang
Pian
Golden Thread (Huang lian), Membranous Milkvetch Root (Huang qi), Honeysuckle
Flower (Jin ying hua)
5 Jiangtangjia
Pian
Membranous Milkvetch Root (Huang qi), King Solomonseal Rhizome (Huang jing),
Heterophylly Falsestarwort Root (Tai zi shen), Rehmannia Root (Di huang), Mongolian
Snakegourd Root (Tian hua fen)
6 Kelening
Jiaonang
Membranous Milkvetch Root (Huang qi), King Solomonseal Rhizome (Huang jing),
Heterophylly Falsestarwort Root (Di huang), Rehmannia Root (Tai zi shen), Mongolian
Snakegourd Root (Tian hua fen), etc.
7 Xiaotangling
Jiaonang
Ginseng (Ren shen), Golden Thread (Huang lian), Mongolian Snakegourd Root (Tian hua
fen), Eucommia Bark (Du zhong), Membranous Milkvetch Root (Huang qi), Danshen
Root (Dan shen), Barbary Wolfberry Fruit (Gou qi zi), Flastem Milkvetch Seed (Sha yuan
zi), White Paeony Root (Bai shao), Common Anemarrhena Rhizome (Zhi mu), Chinese
Magnoliavine Fruit (Wu wei zi), glibenclamide
8 Yangyin
Jiangtang Pian
Membranous Milkvetch Root (Huang qi), Szechwon Tangshen Root (Dang shen),
Kudzuvine Root (Ge gen), Barbary Wolfberry Fruit (Gou qi zi), Figwort Root (Xuan
shen), Fragrant Solomonseal Rhizome (Yu zhu), Rehmannia Root (Di huang), Common
Anemarrhena Rhizome (Zhi mu), Tree Peony Bark (Mu dan pi), Szechuan Lovage
Rhizome (Chuang xin), Giant Knotweed Rhizome (Hu zhang), Chinese Magnoliavine
Fruit (Wu wei zi)
9 Shenqi
Jiangtang Keli
Ginsenosides from Ginseng stems and leaves, Membranous Milkvetch Root (Huang qi),
Rehmannia Root (Di huang), Barbary Wolfberry Fruit (Gou qi zi), Indian Bread (Fu ling),
Wingde Yan Rhizome (Shan yao), Mongolian Snakegourd Root (Tian hua fen), Dwarf
Lilyturf Tuber (Mai dong), Chinese Magnoliavine Fruit (Wu wei zi), Palmleaf Raspberry
Fruit (Fu peng zi), Oriental Waterplantain Rhizome (Ze xie)
10 Jiangtangshu
Jiaonang
Ginseng (Ren shen), Barbary Wolfberry Fruit (Gou qi zi), Membranous Milkvetch Root
(Huang qi), Manyprickle Acanto-Panax Root (Ci wu jia), King Solomonseal Rhizome
(Huang jing), Sharpleaf Galangal Fruit (Yi zhi ren), Oyster Shell (Mu li), Rehmannia Root
(Di huang), Prepared Rehmannia Root (Shou Di huang), Kudzuvine Root (Ge gen),
Danshen Root (Dan shen), Lychee Seed (Li zhi he), Common Anemarrhena Rhizome (Zhi
mu), Gypsum (Shi gao), Gordon Euryale Seed (Qian shi), Wingde Yan Rhizome (Shan
yao), Figwort Roo (Xuan shen), Chinese Magnoliavine Fruit (Wu wei zi), Dwarf Lilyturf
Tuber (Mai dong), Combined Spicebush Root (Wu yao), Mongolian Snakegourd Root
(Tian hua fen), Bitter Orange (Zhi ke)
11 Xiaokeping
Pian
Ginseng (Ren shen), Golden Thread (Huang Lian), Mongolian Snakegourd Root (Tian
hua fen), Cochinchnese Asparagus Root (Tian dong), Membranous Milkvetch Root
(Huang qi), Dan shen root, Barbary Wolfberry Fruit (Gou qi zi), Flastem Milkvetch Seed
(Sha yuan zi), Kudzuvine Root (Ge gen), Common Anemarrhena Rhizome (Zhi mu),
Chinese Magnoliavine Fruit (Wu wei zi), Chinese Gall (Wu bei zi)
12 Xiaokean
Jiaonang
Rehmannia Root (Di huang), Common Anemarrhena Rhizome (Zhi mu), Golden Thread
(Huang Lian), Chinese Wolfberry Root Bark (Di gu pi), Barbary Wolfberry Fruit (Gou qi
zi), Fragrant Solomonseal Rhizome (Yu zhu), Ginseng (Ren shen), Danshen Root (Dan
shen)
13
Qizhi
Jiangtang
Jiaonang
Membranous Milkvetch Root (Huang qi), Rehmannia Root (Di huang), King Solomonseal
Rhizome (Huang jing), Leech (Shui zhi)
14 Xiaoke
Jiangtang Pian
Bud of sugarcane node (Zhe ji), King Solomonseal Rhizome (Huang jing), Stevia
rebaudiana (Tian ye ju), Mulberry Fruit (Sang shen), Wingde Yan Rhizome (Shan yao),
Mongolian Snakegourd Root (Tian hua fen), Ginseng (Ren shen)Evidence-Based Complementary and Alternative Medicine 5
Table 1: Continued.
No. Products Ingredients
15
Zhenqi
Jiangtang
Jiaonang
Membranous Milkvetch Root (Huang qi), King Solomonseal Rhizome (Huang jing), pearl,
Dwarf Lilyturf Tuber (Mai dong), Chinese Angelica (Dan gui), Danshen Root (Dan shen),
Chinese Magnoliavine Fruit (Wu wei zi), Heterophylly Falsestarwort Root (Tai zi shen).
16 Yijin Jiangtang
Jiaonang
Ginseng (Ren shen), Indian Bread (Fu ling), Large head Atractylodes Rhizome (Bai shu),
Cholla Stem (Xian ren zhang), Liquoric Root (Gan cao)
17 Shenhua
Xiaoke Cha
Chinese Dodder Seed (Tu si zi), Ginseng (Ren shen), Mongolian Snakegourd Root (Tian
hua fen), Common Anemarrhena Rhizome (Zhi mu), Saﬄower (Hong hua), Gypsum (Shi
gao), Green tea, Chinese Wolfberry Root Bark (Di gu pi), Reed Rhizome (Lu gen),
Fragrant Solomonseal Rhizome (Yu zhu), Membranous Milkvetch Root (Huang qi),
Kudzuvine Root (Ge gen), Platycodon Root (Jie geng)
18 Yusanxiao
Jiaonang
Membranous Milkvetch Root (Huang qi), Rehmannia Root (Di huang), Prepared
Rehmannia Root (Shou Di huang), Dwarf Lilyturf Tuber (Mai dong), Cochinchnese
Asparagus Root (Tian dong), Figwort Root (Xuan shen), Chinese Magnoliavine Fruit (Wu
wei zi), Epimedium Herb (Yin yang huo), Danshen Root (Dan shen), Saﬄower (Hong
hua), Chinese Angelica (Dang gui), Golden Thread (Huang Lian), Ginseng (Ren shen),
Hairy Antler (Lu rong), Common Anemarrhena Rhizome (Zhi mu), Szechwon Tangshen
Root (Dang shen), Mongolian Snakegourd Root (Tian hua fen)
19 Jiangtangning
Jiaonang
ginseng (Ren shen), Wingde Yan Rhizome (Shan yao), Gypsum (Shi gao), Common
Anemarrhena Rhizome (Zhi mu), Membranous Milkvetch Root (Huang qi), Mongolian
Snakegourd Root (Tian hua fen), Indian Bread (Fu ling), Dwarf Lilyturf Tuber (Mai dong),
Rehmannia Root (Di huang), Chinese Wolfberry Root Bark (Di gu pi), Corn Stigma (Yu
mi xu), Common Macrocarpium Fruit (Shan zhu yu), Liquoric Root (Gan cao)
20 Tangniaole
Jiaonang
Mongolian Snakegourd Root (Tian hua fen), Wingde Yan Rhizome (Shan yao), Ginseng
(Ren shen), Membranous Milkvetch Root (Huang qi), Rehmannia Root (Di huang),
Barbary Wolfberry Fruit (Gou qi zi), Common Anemarrhena Rhizome (Zhi mu),
Cochinchnese Asparagus Root (Tian dong), India Bread (Fu ling), Common
Macrocarpium Fruit (Shan zhu yu), Chinese Magnoliavine Fruit (Wu wei zi), Kudzuvine
Root (Ge gen), Chicken’s Gizzard-membrane (Ji nei jin)
21 Yuye Xiaoke
Chongji
Membranous Milkvetch Root (Huang qi), Kudzuvine Root (Ge gen), Wingde Yan
Rhizome (Shan yao), Common Anemarrhena Rhizome (Zhi mu), Mongolian Snakegourd
Root (Tian hua fen), Chicken’s Gizzard-membrane (Ji nei jin), Chinese Magnoliavine
Fruit (Wu wei zi), Heterophylly Falsestarwort Root (Tai zi shen)
22 Yuquan Pian
Rehmannia Root (Di huang), India Bread (Fu ling), Liquoric Root (Gan cao), Kudzuvine
Root (Ge gen), Membranous Milkvetch Root (Huang qi), Dwarf Lilyturf Tuber (Mai
dong), Ginseng (Ren Shen), Mongolian Snakegourd Root (Tian hua fen), Smoked Plum
(Wu mei), Chinese Magnoliavine Fruit (Wu wei zi)
23 Shenqi Xiaoke
Keli
Ginseng (Ren shen), Membranous Milkvetch Root (Huang qi), Wingde Yan Rhizome
(Shan yao), Atractylodes Rhizome (Bai shu), Chinese Magnoliavine Fruit (Wu wei zi),
Dwarf Lilyturf Tuber (Mai dong), Fragrant Solomonseal Rhizome (Yu zhu), Rehmannia
Root (Di huang), Medicinal Cyathula Root (Niu xi), India Bread (Fu ling), Oriental
Waterplantain Rhizome (Ze xie), Arctium lappaL (Niu ban zi), bombyx batryticatus (Jiang
Can)
24 Ganlou Xiaoke
Keli
Prepared Rehmannia Root (Shu Di huang), Rehmannia Root (Di huang), Barbary
Wolfberry Fruit (Gou qi zi), Chinese Wolfberry Root Bark (Di gu pi), Common
Macrocarpium Fruit (Shan zhu yu), Figwort Root (Xuan shen), Ginseng (Ren shen),
Dangshen root (Dang shen), Membranous Milkvetch Root (Huang qi), Chinese Dodder
Seed (Tu si zi), Mongolian Snakegourd Root (Tian hua fen), Chinese Angelica (Dang gui),
Golden Thread (Huang Lian), Atractylodes Rhizome (Bai shu), Ootheca Mantidis (Sang
piao xiao), Cochinchnese Asparagus Root (Tian dong), Dwarf Lilyturf Tuber (Mai dong),
Oriental Waterplantain Rhizome (Ze xie), India Bread (Fu ling)
25 Kangji Xiaoke
Pian
Ginseng (Ren shen), Golden Thread (Huang Lian), Cortex Phllodedri (Huang bo),
Rehmannia Root (Di huang), Prepared Rehmannia Root (Shu Di huang), Barbary
Wolfberry Fruit (Gou qi zi), Fragrant Solomonseal Rhizome (Yu zhu), Dwarf Lilyturf
Tuber (Mai dong), Chinese Magnoliavine Fruit (Wu wei zi)
26 Xiaokeling
Pian
Rehmannia Root (Di huang), Chinese Magnoliavine Fruit (Wu wei zi), Dwarf Lilyturf
Tuber (Mai dong), Tree Peony Bark (Mu dan pi), Membranous Milkvetch Root (Huang
qi), Golden Thread (Huang Lian), India Bread (Fu ling), Ginseng (Ren shen), Mongolian
Snakegourd Root (Tian hua fen), Gypsum (Shi gao), Barbary Wolfberry Fruit (Gou qi zi)6 Evidence-Based Complementary and Alternative Medicine
Table 1: Continued.
No. Products Ingredients
27 Jiantang
Jiaonang
Ginseng (Ren shen), Common Anemarrhena Rhizome (Zhi mu), Sankezhen (San ke
zhen), Rhizoma Zingiberis (Gan jiang), Chinese Magnoliavine Fruit (Wu wei zi),
Ginsenosides from Ginseng stems and leaves
28 Jiangtang Wan
Ginseng (Ren shen), Membranous Milkvetch Root (Huang qi), King Solomonseal
Rhizome (Huang jing), India Bread (Fu ling), Atractylodes Rhizome (Bai shu), Golden
Thread (Huang Lian), Kudzuvine Root (Ge gen), Chinese Magnoliavine Fruit (Wu wei zi),
Chinese rhubarb (Da huang, Liquoric Root (Gan cao)
29 Tangniaoling
Pian
Mongolian Snakegourd Root (Tian hua fen), Kudzuvine Root (Ge gen), Rehmannia Root
(Di huang), Dwarf Lilyturf Tuber (Mai dong), Chinese Magnoliavine Fruit (Wu wei zi),
Liquoric Root (Gan cao), Fried glutinous rice, pumpkin powder
30 Tangle Pian
Mongolian Snakegourd Root (Tian hua fen), Wingde Yan Rhizome (Shan yao),
Rehmannia Root (Di huang), Ginseng(Ren shen), Membranous Milkvetch Root (Huang
qi), Barbary Wolfberry Fruit (Gou qi zi), India Bread (Fu ling), Common Anemarrhena
Rhizome (Zhi mu), Oriental Waterplantain Rhizome (Ze xie), Tree Peony Bark (Mu dan
pi), Common Macrocarpium Fruit (Shan zhu yu), wheatgerm
Chinese magnoliavine fruit
Kudzuvine root
Dwarf lilyturf tuber
Common anemarrhena rhizome
Barbary wolfberry fruit
India bread
Golden thread
Wingde yan rhizome
King solomonseal rhizome
Danshen root
root Liquoric
Fragrant solomonseal rhizome
Heterophylly falsestarwort root
Figwort root
Gypsum
Chinese wolfberry root bark
Cochinchnese asparagus root
Oriental waterplantain rhizome
Common macrocarpium fruit
Atractylodes rhizome
Dangshen root
Chinese angelica
Tree peony bark
Membranous milkvetch root
Rehmannia root
Mongolian snakegourd root
Ginseng
02468 1 0 1 2 1 4 1 6 1 8 2 0 2 2 2 4 2 6 2 8 3 0
Frequency prescribed in 30 traditional chinese formulas
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Table 2: Classiﬁcations of functions of TCM prescribed in 30 traditional Chinese formulas.
Classiﬁcations of functions TCM (Chinese name, times prescribed in 30 formulas)
Invigorating Qi (energy)
Membranous Milkvetch Root (Huang qi, 23)
Ginseng (Ren shen, 18)
Barbary Wolfberry Fruit (Gou qi zi, 11)
Wingde Yan Rhizome (Shan yao, 9)
Liquoric Root (Gan cao, 6)
Heterophylly Falsestarwort Root (Tai zi shen, 4)
Atractylodes Rhizome (Bai shu, 4)
Dangshen Root (Dang shen, 3)
Nourishing Yin (body ﬂuids)
Rehmannia Root (Di huang, 22)
Mongolian Snakegourd Root (Tian hua fen, 19)
Chinese Magnoliavine Fruit (Wu wei zi, 18)
Dwarf Lilyturf Tuber (Mai dong, 13)
King Solomonseal Rhizome (Huang jing, 8)
Fragrant Solomonseal Rhizome (Yu zhu, 5)
Cochinchnese Asparagus Root (Tian dong, 4)
Common Macrocarpium Fruit (Shan zhu yu, 4)
Cochinchnese Asparagus Root (Tian dong, 4)
Clearing heat
Common Anemarrhena Rhizome (Zhi mu, 12)
Kudzuvine Root (Ge gen, 11)
Golden Thread (Huang Lian, 9)
Figwort Root (Xuan shen, 4)
Gypsum (Shi gao, 4)
Chinese Wolfberry Root Bark (Di gu pi, 4)
Tree Peony Bark (Mu dan pi, 3)
Reducing stasis (improving
blood circulation and kidney
function)
India Bread (Fu ling, 10)
Danshen Root (Dan shen, 7)
Oriental Waterplantain Rhizome (Ze Xie, 4)
Chinese Angelica (Dang gui, 3)
T2DMpatients[85].AlthoughXKWwasclaimedtobemore
safe than glibenclamide to a certain extent, herb medicine
components cannot completely resist the untoward eﬀect of
glibenclamide. To be particular, overuse should be avoided
this formula contained glibenclamide which easily cause
because severe hypoglycemic response after overuse. Indeed,
it had a severe hypoglycemic response in 36 cases of T2DM
patients [86].
3.12. Jinqi Jiangtang Pian. Jinqi Jiangtang Pian (JQJT) had
a moderate antihyperglycemic eﬀe c ti nm i l do rm o d e r a t e
T2DM patients but had no signiﬁcant eﬀect in severe T2DM
patients when it was used alone [87]. Nevertheless, its use
combined with positive drug such as glibenclamide had
better eﬀects in T2DM patients after the treatment than
glibenclamide alone [88], even when those positive drugs
could not work well in those patients [87]. In addition,
JQJT combined with positive drugs (such as metformin,
Acarbose or glibenclamide) might have more improvement
in diabetic dyslipidemia [89] and the early development of
diabetic nephropathy [90] than positive drugs alone. The
eﬀe c to fJ Q J Tw a sc o n ﬁ r m e di n3 0c a s e so fT 2 D Mr e c e n t l y
once more [91]. In addition, eﬀective interventions of JQJT
on prediabetes were conducting [92] since prediabetes was
a growing health concern where a large percentage of
these patients develop full T2DM. Its antihyperglycemic
action was related to improvement of insulin sensitivity by
comprehensive mechanisms, for example, reducing serum
lipid, regulating immune functions, enhancing antioxidative
systems, and improving micro-circulation and beta-cell
function [93]. JQJT had no signiﬁcant adverse eﬀects in
T2DM patients.
3.13. Jiangtangjia Pian and Kelening Jiaonang. Jiangtangjia
Pian (JTJ) is used to treat T2DM patients. Among 48 cases
of T2DM patients, JTJ improved blood glucose control after
the treatment combined with antidiabetic drugs such as
sulfonylureas, biguanides, and insulin [94]. Interestingly,
in this study, blood glucose was poor controlled in these
patients of T2DM by using those antidiabetic drugs before
the use of JTJ. Furthermore, its single use also had antihyper-
glycemic eﬀect in 10 newly diagnosed T2DM patients. Herbs
in Kelening Jiaonang (KLL) were similar to Jiangtangjia Pian
but might have diﬀerent oral dosage or prepared process.
This formula was used to treat T2DM patients. In clinical
report, KLL signiﬁcantly lowered blood glucose level in
T2DM patients (n = 30) combined with regular antidiabetic
drugs after treatment compared with that before treatment
[95]. Glibenclamide in combination with KLL in treatment
of T2DM patients (n = 3 3 )w a sm o r ee ﬀective and less
toxic than its single use [96]. KLL for 1 month of oral
administration signiﬁcantly improved blood glucose levels8 Evidence-Based Complementary and Alternative Medicine
(+) anti-hyperglycemic eﬀect eﬀects
Routine anti-hyperglycemic drugs
Classic TCM
Huang qi Di Huang Zhi mu Dan shen
(−) diabetic syndromes or complications
(+) Qi (+) Yin (−) Heat (+) Blood
Figure 2: Antidiabetic eﬀects of classic traditional Chinese herbs and their action model in treatment of T2DM patients based on the theory
of traditional Chinese medicine.
in 30 cases of T2DM patients who administrated regular
antidiabetic drugs but had poor control [97]. Also, 8 weeks
of treatment of KLL had a signiﬁcant improvement in blood
glucose in those T2DM patients (n = 21) with sulfanylurea
failure, which indicated that KLL might improve insulin
resistance [98]. Both JTJ and KLL reduced the blood glucose
and increased body weight in alloxan-induced diabetic mice
[99, 100], suggesting that these drugs might exert an insulin-
like eﬀects. No signiﬁcant adverse eﬀects were reported of
these herbs.
3.14. Xiaotangling Jiaonang. Xiaotangling Jiaonang (XTL)
is another formula contained both herb medicines and
glibenclamide. It was reported that XTL had signiﬁcant
antihyperglycemic eﬀectin 30 cases of T2DM after treatment
compared with that before treatment [101]. Among 44
cases of T2DM, 88.6% of patients showed signiﬁcant and
moderate improvement after XTL treatment while 75.0%
of those patients (n = 32) treated with positive control
showed the eﬀect [102]. About 98.67% of T2DM patients
(n = 150) treated with XTL in combination with metforminEvidence-Based Complementary and Alternative Medicine 9
showed signiﬁcant or moderate improvement in diabetic
symptoms and other compications (diabetic dyslipidemia
andbloodﬂuidparameters)whileonly78%ofthosepatients
(n = 50) treated with metformin showed similar eﬀects
[103]. In addition, management of XTL eﬀectively improved
blood glucose control in 66.7% of diabetic patients (n = 24)
with secondary failure of sulfanylurea [104]; XTL treatment
also increased insulin sensitivity index in T2DM patients
(n = 47)comparedwithglibenclamide(n = 35),whichindi-
cated that treatment of XTL could improve insulin resistance
in T2DM patients. Antihyperglycemic mechanisms of XTL
are related to improve insulin sensitivity in T2DM patients.
We should be cautious of their hypoglycemic events since
XTL contained glibenclamide as XKW did.
3.15. Shenqi Jiangtang Keli. Shenqi Jiangtang Keli (SQJT)
is clinically used in T2DM patients. In a clinical study,
82.85% of T2DM patients (n = 35) show appreciable eﬀects
after SQJT treatment [105]. SQJT signiﬁcantly enhanced
the antihyperglycemic eﬀect of metformin in 30 cases of
T2DM patients [106]. SQJT alone had signiﬁcant antidia-
betic eﬀect in 235 cases of T2DM patients compared with
diet or exercise-controlled controls. But most of patients
were diagnosed as slight or mild cases [107]. SQJT mainly
improved the diabetic syndromes and even exerted a antihy-
perglycemic eﬀect in T2DM patients with secondary-failure
to sulfonylureas [108]. Antidiabetic mechanisms of SQJT are
related to improve insensitivity [109] and restore functions
of pancreatic islets in T2DM patients [110]. SQJT had no
signiﬁcant adverse eﬀects.
3.16. Other TCM
3.16.1. Yangyin Jiangtang Pian. In a clinical study [111],
95.8% of T2DM patients (n = 120) treated with Yangyin
Jiangtang Pian (YYJT) in combination with metformin
showed a signiﬁcant and moderate improvement in diabetic
symptoms while this eﬀect was done only in 72.5% of the
patients treated with metformin (n = 40). YYJT lowered
blood glucose, increased insulin levels, enhanced insulin
sensitivity, and improved blood ﬂuid parameters in alloxan-
induced diabetic rats [111]. No signiﬁcant adverse eﬀects
were documented of YYJT.
3.16.2. Xiaoke Jiangtang Pian. Xiaoke Jiangtang Pian (XKJT)
had signiﬁcant antihyperglycemic in T2DM patients (70% of
30 cases show appreciable eﬀect) [112]. XKJT also showed a
signiﬁcant glucose-lowering eﬀect in alloxan-reduced mice.
In acute and subacute toxicological trials, no signiﬁcant
adverse eﬀects were observed in rats or dogs.
3.16.3. Yijin Jiangtang Jiaonang. Among 42 cases of T2DM
patients treated with Yijin Jiangtang Jiaonang (YJJT), about
78.6%, 83.3%, and 45.2% of patients showed appreciable
decrease in fasting blood glucose, postprandial blood glu-
cose, and HbA1c levels, respectively [113]. In addition, YJJT
had signiﬁcant decrease in blood triglycerides and total
cholesterol levels. YJJT might exert antidiabetic activities
through enhancing insulin sensitivity. No hypoglycemic
events or any signiﬁcant adverse eﬀect was recorded.
4. DiscussionandPerspective
4.1. The Theory of TCM Plays a Fundamental Role in
Prescribing TCM in Treatment of T2DM Patients. In this
review, for single-herb prescriptions, Ginseng, Bitter melon,
Golden Thread, Fenugreek, Garlic, and Cinnamon might
haveantidiabeticeﬀectsinT2DMpatients.Among30antidi-
abetic formulas approved by China SFDA, top 10 of the most
frequently prescribed herbs are Membranous Milkvetch
Root, Rehmannia Root, Mongolian Snakegourd Root, Gin-
seng, Chinese Magnoliavine Fruit, Kudzuvine Root, Dwarf
Lilyturf Tuber, Common Anemarrhena Rhizome, Barbary
Wolfberry Fruit, India Bread, which mainly guided by the
theory of TCM. In spite of diversity of Chinese formulas,
someherb componentsarefrequentlypresentedin formulas.
Based on the theory of TCM, most of these Chinese herbs
investigated can be grouped as Qi (energy)-invigorating, Yin
(body ﬂuids)-nourishing, Heat (body heat)-clearing, and
Stasis (congestedblood circulation orurine)-reducing drugs,
and so forth. Diabetes (named Xiaoke in the theory of TCM)
is usually associated with the deﬁciency of both Qi (energy)
and Yin (body ﬂuids) and results in the Heat of tissues
and blood or urine Stasis (congested blood circulation or
urine) [114]. This may show the syndromes of Shang Xiao
(impairment of the body ﬂuid by the lung-heat), Zhong
Xiao (excessive blazing heat in the stomach), and Xia xiao
(deﬁciency of the kidney-Yin, deﬁciency of both Yin and
Yang) in TCM. Those prescribed herbs might be eﬀective to
treat the diabetic syndromes in TCM. Although the theory of
TCM is diﬃcult to understand, it is very useful to direct us
to develop eﬀective traditional Chinese herbs with systemic
antidiabetic activities. Figure 2 indicates the action model of
TCM in treatment of T2DM patients. Indeed, the rich and
colorful TCM may be prescribed according to the diversity
of diabetic syndromes or complications, which is similar
to personalized therapy in western medicine [115]. In the
future, we might select these highly frequently prescribed
herbs as further study in order to disclose their scientiﬁc
nature.
4.2. TCM Serve As Eﬀective Complementary and Alternative
Medicine in Treatment of T2DM Patients. As described
above,TCMserveaseﬀectivecomplementaryandalternative
medicine in treatment of T2DM patients although part of
results is acquired by poor designs or controls. Most of TCM
showed promising results on antidiabetic eﬀects in com-
bination with routine antidiabetic treatment. A very small
amount of TCM could alone get satisﬁed antidiabetic eﬀects
in those T2DM patients newly diagnosed or with the failure
of routine antidiabetic treatments. In addition, most of TCM
are lower cost, more eﬀective for some speciﬁc complica-
tions, and less adverse eﬀect than regular antihyperglycemic
drugs. This may also be the reasons why TCM are popular
as complementary and alternative medicine in treatment of
syndromes of T2DM. Action mechanisms of TCM mainly10 Evidence-Based Complementary and Alternative Medicine
involved in improving insulin sensitivity, stimulating insulin
secretion, protecting pancreatic islets, inhibiting intake of
intestinal carbohydrates, and so on. These actions may play
an important role in serving as eﬀective complementary and
alternative medicines to routine antidiabetic drugs.
Taken together, TCM, especially for those herbs with a
high prescription frequency, are hopeful to serve as eﬀective
complementary and alternative medicine in treatment of
T2DM patients based on the theory of TCM. However, active
components of TCM are still far from our knowledge since
TCM are usually consisted of more than 2 herbs and each
herb contains hundreds of compounds. We should establish
some appropriate methods to deﬁne the active components
of TCM and to guarantee stable pharmacological and clinical
eﬀects.Ontheotherhand,pharmacologicalorclinicaleﬀects
of TCM should be further validated in future studies since
part of results is acquired by poor designs or controls.
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